Pharmacological modulation of HDAC4 activity or localization corrected cellular phenotypes previously described in PD GBA-N370S patient-derived dopamine neurons, alleviating ER stress to reduce autophagic induction, suggesting HDAC4 as a therapeutic target for PD. The gene discussed is HDAC4; the disease is Parkinson disease.